PWPaul Robert Wheeler

Paul Robert Wheeler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul Robert Wheeler has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Nicholas G. Coldham

    Tuberculosis Research Group, Veterinary Laboratories Agency (Weybridge), New Haw, Surrey, KT15 3NB, United Kingdom,1 Department of Animal Sciences, University of Hyderabad, Hyderabad 500 046, India2

    3 shared publications
  • R. Glyn Hewinson

    Tuberculosis Research Group, Veterinary Laboratories Agency (Weybridge), New Haw, Surrey, KT15 3NB, United Kingdom,1 Department of Animal Sciences, University of Hyderabad, Hyderabad 500 046, India2

    3 shared publications
  • Stephen Vincent Gordon

    UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland

    3 shared publications
  • Adam F. Cunningham

    Institute of Immunology and Immunotherapy, University of Birmingham

    2 shared publications
  • Christopher W. Wharton

    School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK

    2 shared publications
  • Claire L. Spreadbury

    Division of Immunity and Infection, University of Birmingham, Birmingham B15 2TT, UK

    2 shared publications

Latest Publications

  • Open Access

    Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis

    by Farahnaz Movahedzadeh, Paul R Wheeler, Premkumar Dinadayala, Yossef Av-Gay, Tanya Parish, Mamadou Daffé, Neil G Stoker

    Mycobacteria use inositol in phosphatidylinositol, for anchoring lipoarabinomannan (LAM), lipomannan (LM) and phosphatidylinosotol mannosides (PIMs) in the cell envelope, and for the production of mycothiol, which maintains the redox balance of the cell. Inositol is synthesized by conversion of glucose-6-phosphate to inositol-1-phosphate, followed by dephosphorylation by inositol monophosphate phosphatases (IMPases) to form myo-inositol. To gain insight into how Mycobacterium tuberculosis synthesises inositol we carried out genetic analysis of the four IMPase homologues that are present in the Mycobacterium tuberculosis genome.


  • Global Effects of Inactivation of the Pyruvate Kinase Gene in the Mycobacterium tuberculosis Complex

    by Sivagamisundaram Chavadi, Esen Wooff, Nicholas G. Coldham, Manjula Sritharan, R. Glyn Hewinson, Stephen V. Gordon, Paul R. Wheeler

    To better understand the global effects of “natural” lesions in genes involved in the pyruvate metabolism in Mycobacterium bovis , null mutations were made in the Mycobacterium tuberculosis H37Rv ald and pykA genes to mimic the M. bovis situation. Like M. bovis , the M. tuberculosis Δ pykA mutant yielded dysgonic colonies on solid medium lacking pyruvate, whereas colony morphology was eugonic on pyruvate-containing medium. Global effects of the loss of the pykA gene, possibly underlying colony morphology, were investigated by using proteomics on cultures grown in the same conditions. The levels of Icd2 increased and those of Icl and PckA decreased in the Δ pykA knockout. Proteomics suggested that the synthesis of enzymes involved in fatty acid and lipid biosynthesis were decreased, whereas those involved in β-oxidation were increased in the M. tuberculosis Δ pykA mutant, as confirmed by direct assays for these activities. Thus, the loss of pykA from M. tuberculosis results in fatty acids being used principally for energy production, in contrast to the situation in the host when carbon from fatty acids is conserved through the glyoxylate cycle and gluconeogenesis; when an active pykA gene was introduced into M. bovis , the opposite effects occurred. Proteins involved in oxidative stress—AhpC, KatG, and SodA—showed increased synthesis in the Δ pykA mutant, and iron-regulated proteins were also affected. Ald levels were decreased in the Δ pykA knockout, explaining why an M. tuberculosis Δ pykA Δ ald double mutant showed little additional phenotypic effect. Overall, these data show that the loss of the pykA gene has powerful, global effects on proteins associated with central metabolism.


  • Analysis of Lipid Biosynthesis and Location

    by Paul Robert Wheeler

    A procedure for metabolic labeling of all cellular lipids starting with a culture of mycobacteria is described in this chapter using either a pulse-chase or a simple labeling experimental design. Three fractions are produced for subsequent lipid analysis: (1) the culture filtrate; (2) a readily released surface lipid fraction; and (3) the killed, labeled bacteria. A standardized, TLC-based method for general lipid analysis that can be used to quantify the labeling of all the mycobacterial lipids is given as well as a protocol for analyzing the fatty acyl moieties of the lipids.


  • Analyzing Lipid Metabolism: Activation and β-Oxidation of Fatty Acids

    by Paul Robert Wheeler

    There is massive gene replication predicted for the activation of fatty acids and their entry into the β-oxidation cycle for fatty acid oxidation. These two steps in fatty acid metabolism are catalyzed by FadD and FadE enzymes with 36 genes predicted for each of these respective activities in Mycobacterium tuberculosis. Here we present methods for the cell-free assay of types of enzymes in live bacteria, as well as for fatty acid oxidation overall.


  • Functional analysis of a clonal deletion in an epidemic strain of Mycobacterium bovis reveals a role in lipid metabolism

    by Paul R. Wheeler, Roland Brosch, Nicholas G. Coldham, Jacqueline K. Inwald, R. Glyn Hewinson, Stephen V. Gordon

    Previous work on the population structure of Mycobacterium bovis strains in Great Britain has identified highly successful clones which are expanding across the country. One such clone, designated M. bovis type 17, differs from all other members of the Mycobacterium tuberculosis complex in having a region of deletion, termed RDbovis(d)_0173, of seven genes between Mb1963c and Mb1971. Three of these genes have functions annotated in lipid metabolism. To explore the molecular basis for the success of this clone, we examined the impact of this deletion on lipid metabolism. While type 17 isolates had similar lipid composition to other M. bovis strains, their ability to incorporate propanoate into mycolic acids was remarkably low. When expressed as a reciprocal (the ratio of incorporation of label from acetate : propanoate into mycolic acids) the ratio was higher for all three type 17 field strains tested (mean: 18.90) than the values of 7.30 to 7.61 for other field strains (P<0.002) and values <6.50 for all other strains in the M. tuberculosis complex tested. The label from propanoate was diverted to pyruvate, at significantly higher levels in M. bovis type 17 than all other strains (P<0.021). Complementation of M. bovis type 17 with an integrating cosmid, IE471, carrying the M. tuberculosis orthologues of Mb1963c–Mb1971 resulted in the ability of the recombinant strain to incorporate label from propanoate into mycolic acids in a manner similar to other strains. M. bovis type 17 : : IE471 labelled pyruvate from propanoate about four times more slowly than the parent strain. Thus, RDbovis(d)_0173 results in a profound effect on carbon metabolism, providing the ability to compensate for the inactivation of the ald and pykA genes, involved in pyruvate metabolism, that is seen in M. bovis (but not in M. tuberculosis). This shift in carbon metabolism may be a factor in the extraordinary clonal expansion reported for M. bovis type 17.


  • Open Access

    GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosismetabolism

    by Dany Jv Beste, Tracy Hooper, Graham Stewart, Bhushan Bonde, Claudio Avignone-Rossa, Michael E Bushell, Paul Wheeler, Steffen Klamt, Andrzej M Kierzek, Johnjoe McFadden

    Background: An impediment to the rational development of novel drugs against tuberculosis (TB) is a general paucity of knowledge concerning the metabolism of Mycobacterium tuberculosis, particularly during infection. Constraint-based modeling provides a novel approach to investigating microbial metabolism but has not yet been applied to genome-scale modeling of M. tuberculosis. Results: GSMN-TB, a genome-scale metabolic model of M. tuberculosis, was constructed, consisting of 849 unique reactions and 739 metabolites, and involving 726 genes. The model was calibrated by growing Mycobacterium bovis bacille Calmette Guérin in continuous culture and steady-state growth parameters were measured. Flux balance analysis was used to calculate substrate consumption rates, which were shown to correspond closely to experimentally determined values. Predictions of gene essentiality were also made by flux balance analysis simulation and were compared with global mutagenesis data for M. tuberculosis grown in vitro. A prediction accuracy of 78% was achieved. Known drug targets were predicted to be essential by the model. The model demonstrated a potential role for the enzyme isocitrate lyase during the slow growth of mycobacteria, and this hypothesis was experimentally verified. An interactive web-based version of the model is available. Conclusion: The GSMN-TB model successfully simulated many of the growth properties of M. tuberculosis. The model provides a means to examine the metabolic flexibility of bacteria and predict the phenotype of mutants, and it highlights previously unexplored features of M. tuberculosis metabolism.


  • Open Access

    Functional Demonstration of Reverse Transsulfuration in the Mycobacterium tuberculosis Complex Reveals That Methionine Is the Preferred Sulfur Source for Pathogenic Mycobacteria

    by Paul R. Wheeler, Nicholas G. Coldham, Lisa Keating, Stephen V. Gordon, Esen E. Wooff, Tanya Parish, R. Glyn Hewinson


  • Open Access

    Tubercle bacilli generate a novel cell wall-associated pigment after long-term anaerobic culture

    by Adam F. Cunningham, Peter R. Ashton, Claire L. Spreadbury, David A. Lammas, Rachel Craddock, Christopher W. Wharton, Paul R. Wheeler

    Many cases of tuberculosis result from reactivation of previously acquired latent infections. Models to study such persister forms often involve gradual depletion of oxygen during culture as poor aeration is a characteristic of non-progressive TB granulomas. Anaerobically cultured bacilli develop a thickened outer-most cell wall layer. Here, we analyzed this layer from anaerobically cultured Mycobacterium tuberculosis and Mycobacterium bovis BCG. By six weeks of anaerobiosis a pigment was detected at levels >60-fold higher in anaerobic than aerobic bacilli. This pigment was responsible for the electron-dense appearance of the thickened cell wall layer and gave an electrospray mass spectrometry peak at 409 Da (M + Na)+ or (M + H)+. We termed this pigment APP1, anaerobically produced pigment 1, the first pigment identified in M. tuberculosis.


  • Open Access

    Tubercle bacilli generate a novel cell wall-associated pigment after long-term anaerobic culture

    by Adam F. Cunningham, Peter R. Ashton, Claire L. Spreadbury, David A. Lammas, Rachel Craddock, Christopher W. Wharton, Paul R. Wheeler

    Many cases of tuberculosis result from reactivation of previously acquired latent infections. Models to study such persister forms often involve gradual depletion of oxygen during culture as poor aeration is a characteristic of non-progressive TB granulomas. Anaerobically cultured bacilli develop a thickened outer-most cell wall layer. Here, we analyzed this layer from anaerobically cultured Mycobacterium tuberculosis and Mycobacterium bovis BCG. By six weeks of anaerobiosis a pigment was detected at levels >60-fold higher in anaerobic than aerobic bacilli. This pigment was responsible for the electron-dense appearance of the thickened cell wall layer and gave an electrospray mass spectrometry peak at 409 Da (M + Na)+ or (M + H)+. We termed this pigment APP1, anaerobically produced pigment 1, the first pigment identified in M. tuberculosis.